| Literature DB >> 34934666 |
Karalanglin Tiewsoh1, Akshita Soni1, Lesa Dawman1, Nitin J Peters2, Muneer A Malik2.
Abstract
INTRODUCTION: Chronic peritoneal dialysis (CPD) is an important modality of renal replacement therapy (RRT) in children of all ages with end-stage renal disease (ESRD). We retrospectively assessed the clinical profile of children with chronic kidney disease (CKD) initiated on CPD at a tertiary care centre in Northern India.Entities:
Keywords: Children; chronic kidney disease; chronic peritoneal dialysis; peritonitis
Year: 2021 PMID: 34934666 PMCID: PMC8653466 DOI: 10.4103/jfmpc.jfmpc_250_21
Source DB: PubMed Journal: J Family Med Prim Care ISSN: 2249-4863
Chronic kidney disease prevalence data from registries across the globe
| NAPRTCS | ANZDATA | ESPN/ERA-EDTA | CKDRI | |
|---|---|---|---|---|
| Country | North America | Australia + New Zealand | Europe | India |
| Year of beginning | 1987-Transplants only | 1991 | 2006-RRT | 2006 |
| Age range | ≤20 | ≤17 | ≤14 | ≤18 |
| Scope | ≥ Stage 3 | ESRD | ESRD | ≥ Stage 3 |
| Number of cases | 7039 (1992-2010) | 323 (2011-2016) | 531 (2015) | 948 (2006-2009) |
*NAPRTCS: North American Paediatric Renal Trials and Collaborative Studies, ANZDATA: Australia and New Zealand Dialysis and Transplant Registry, ESPN/ERA-EDTA: European Registry for Children on Renal Replacement Therapy, CKDRI: Chronic kidney disease registry of India
Demographic, clinical and laboratory profiles of children with chronic kidney disease
| Variables | Values |
|---|---|
| Age at onset of symptoms (months) | |
| Mean (SD) | 60.61 (44.4) |
| Median (IQR) | 81 (11-90) |
| Age at diagnosis (months) | |
| Mean (SD) | 67.07 (43.14) |
| Median (IQR) | 81 (36-103) |
| Serum creatinine at initiation of PD (mg/dL) | |
| Mean (SD) | 6.97 (3.22) |
| Median (IQR) | 6.3 (4.25-8.4) |
| eGFR at initiation of PD (mL/1.73 m2) | |
| Mean (SD) | 7.18 (2.84) |
| Median (IQR) | 6.45 (5.59-8.6) |
| Age at catheter insertion (months) | |
| Mean (SD) | 82.38 (38.39) |
| Median (IQR) | 92.22 (74.27-107.80) |
| Age at initiation (months) | |
| Mean (SD) | 82.94 (38.52) |
| Median (IQR) | 92.97 (74.43-108.79) |
| Weight at initiation (kgs) | |
| Mean (SD) | 16 (5.75) |
| Median (IQR) | 16.2 (15-18.9) |
| Height at initiation (cm) | |
| Mean (SD) | 104.2 (18.82) |
| Median (IQR) | 110 (95.6-114.3) |
| Body Mass Index at initiation | |
| Mean (SD) | 14.79 (1.88) |
| Median (IQR) | 14.32 (13.15-16.42) |
| Gap between insertion of catheter and initiation of dialysis (days) | |
| Mean (SD) | 17.08 (10.96) |
| Median (IQR) | 15 (12-23) |
| Follow-up duration (days) | |
| Mean (SD) | 191.77 (139.77) |
| Median (IQR) | 175 (85-249) |
| Time to onset of peritonitis (days) | |
| Mean (SD) | 96.5 (128.39) |
| Median (IQR) | 52 (11-137.5) |
*SD: Standard deviation, IQR: Interquartile range, PD: Peritoneal dialysis
Comparison of biochemical parameters at presentation and at onset of PD
| At presentation | At PD initiation | |
|---|---|---|
| Serum creatinine (mg/dL) | ||
| Mean (SD) | 3.12 (0.61) | 3.09 (0.62) |
| Median (IQR) | 2.8 (2.7-3.4) | 3 (2.8-3.4) |
| Blood urea (mg/dL) | ||
| Mean (SD) | 221.3333 (118.2634) | 146.3077 (72.42627) |
| Median (IQR) | 171 (136-307.5) | 127 (101-206) |
| pH | ||
| Mean (SD) | 7.3328 (0.106427) | |
| Median (IQR) | 7.369 (7.3-7.39) | |
| Hb (gm/dL) | ||
| Mean (SD) | 6.651667 (2.018018) | 7.030769 (1.234494) |
| Median (IQR) | 6.5 (6.025-7.44) | 6.7 (6.3-7.3) |
| Bicarbonate (mmol/L) | ||
| Mean (SD) | 10.38 (5.733516) | 18.57273 (5.432327) |
| Median (IQR) | 7.14 (7.07-12.07) | 19.7 (15.5-23.1) |
| Serum potassium (mmol/L) | ||
| Mean (SD) | 5.02 (0.84) | 4.78 (0.65) |
| Median (IQR) | 4.75 (4.6-5.3) | 4.79 (4.3-5.1) |
| Serum calcium (mg/dL) | ||
| Mean (SD) | 7.16 (1.69) | 6.27 (1.35) |
| Median (IQR) | 7.6 (5.85-8.1) | 7.9 (7.3-8.1) |
| Serum phosphate (mg/dL) | ||
| Mean (SD) | 7.02 (6.3) | 5.15 (2.01) |
| Median (IQR) | 6.3 (5.6-7.55) | 5 (4.1-5.6) |
| Serum ALP (U/L) | ||
| Mean (SD) | 329.46 (340.93) | 242.62 (158.36) |
| Median (IQR) | 222 (121-295.5) | 190 (129-284) |
| S. 25 OH Vit D levels (ng/mL) | ||
| Mean (SD) | 18.01 (17.15) | 38.55 (29.07) |
| Median (IQR) | 10.01 (7.19-20.92) | 26.75 (16.5-58.56) |
| S. PTH (pg/mL) | ||
| Mean (SD) | 608.03 (461.03) | 554.84 (312.87) |
| Median (IQR) | 550.85 (277.68-793.45) | 546.7 (322.6-842.25) |
| S. albumin (g/dL) | ||
| Mean (SD) | 3.12 (0.61) | 3.09 (0.62) |
| Median (IQR) | 2.8 (2.7-3.4) | 3 (2.8-3.4) |
Comparison of CAPD cohorts
| Our study | Prasad | Sinha | Aksu | |
|---|---|---|---|---|
| Study period | 2016-2019 | 1994-2004 | 2011-2014 | 1995-2005 |
|
| 13 | 30 | 23 | 93 |
| Age (months) | ||||
| Median (IQR) | 92.97 (74.43-108.79) | 156 (96) | 110.4 (36-198) | 109 (51.6) |
| Mean (SD) | 82.94 (38.52) | |||
| Male: Female | 5.5:1 | 1.5:1 | 2.85:1 | 1.06:1 |
| Aetiology | PUV (38.46%) | Chronic interstitial | CAKUT | Urological |
| Hypoplastic/dysplastic (38.46%) | Chronic interstitial nephritis (30%) | CAKUT (26.09%) | Urological diseases (49.6%) {VUR (22.6%)} Primary GN (25.9%) | |
| Follow-up (CPD months) | 82 | 438 | - | 2670 |
| Peritonitis rate (episodes per patient-year) | 0.87 | 0.58 | 0.85 | 0.66 |
| Transplant | 15.38% | 23.3% | 35% | 34.4% |
| Mortality | 15.38% | 26.6% | 17% | - |